Puriblood Medical Co., Ltd. (TPEX:6847)
58.30
+8.60 (17.30%)
Apr 29, 2026, 1:36 PM CST
Puriblood Medical Market Cap
Puriblood Medical has a market cap or net worth of 829.61 million as of April 28, 2026. Its market cap has decreased by -41.17% in one year.
Market Cap
829.61M
Enterprise Value
803.64M
Revenue
117.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
58.30
Market Cap Chart
Since November 5, 2021, Puriblood Medical's market cap has decreased from 1.83B to 829.61M, a decrease of -54.63%. That is a compound annual growth rate of -16.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 707.23M | -30.97% |
| Dec 31, 2025 | 1.02B | -28.36% |
| Dec 31, 2024 | 1.43B | -10.67% |
| Dec 29, 2023 | 1.60B | -16.97% |
| Dec 27, 2022 | 1.93B | -16.36% |
| Dec 30, 2021 | 2.31B | 26.07% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TFBS Bioscience | 726.73M |
| Sofiva Genomics | 712.58M |
| Kim Forest Enterprise | 772.96M |
| Pharmigene | 509.70M |
| Genetics Generation Advancement | 1.16B |
| Welgene Biotech | 427.63M |
| DIVA Laboratories | 1.87B |
| BIONET | 3.75B |